Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
416 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
Rank Status Study
21 Available Dupilumab Compassionate Use Study
Condition: Asthma
Intervention: Drug: Dupilumab
22 Temporarily not available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention: Drug: 131-I-meta-iodobenzylguanidine
23 No longer available Study of Cannabidiol for Drug-Resistant Epilepsies
Condition: Drug Resistant Epilepsy
Intervention: Drug: Cannabidiol
24 Temporarily not available Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease
Conditions: CMV Viremia;   CMV Disease
Intervention: Biological: Cytomegalovirus-specific Cytotoxic T Lymphocytes (CMV-CTLs)
25 No longer available Single Patient IND, MLN8237
Condition: Prostate Cancer
Intervention: Drug: MLN8237
26 Available An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC
Conditions: Malignant Neoplasms of Digestive Organs;   Neuroendocrine Tumor;   Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
Interventions: Drug: 68Ga-DOTATOC;   Procedure: PET/CT
27 Available Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation;   Triple-Negative Breast Cancer
Interventions: Drug: Veliparib;   Drug: Cisplatin;   Drug: Vinorelbine
28 Available Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
Condition: Heart Decompensation
Intervention: Drug: Levosimendan
29 Approved for marketing Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
Condition: HDFN
Intervention: Other: zimin Lu,Guo Sa
30 Available A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease
Condition: CLN2 Disease
Intervention: Drug: BMN190, recombinant human tripeptidyl peptidase-1 (rhTPP1)
31 Available Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Drug: Ultratrace Iobenguane I131
32 Available Therasphere for Unresectable Primary or Secondary Liver Neoplasia
Conditions: Liver Cancer;   Liver Neoplasms;   HepatoCellular Carcinoma
Intervention: Device: TheraSphere Treatment
33 Available Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
Conditions: Neoplasm;   Desmoid Tumor
Intervention: Drug: PF-03084014
34 Available Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Conditions: TTR-mediated Amyloidosis;   Amyloidosis, Hereditary;   Amyloid Neuropathies, Familial;   Familial Amyloid Polyneuropathies;   Amyloid Neuropathies;   Amyloidosis, Hereditary, Transthyretin-Related
Intervention: Drug: patisiran (ALN-TTR02)
35 Available The Multi-Center Study of Shear Wave Elastography on Thyroid Nodules
Condition: Thyroid Nodules
Intervention: Device: SWE
36 Temporarily not available HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option
Condition: Anemia
Intervention: Drug: HBOC-201
37 Available Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD
Condition: Total Parenteral Nutrition-induced Cholestasis
Intervention: Drug: Omegaven IV lipid emulsion
38 Available Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children
Condition: Parenteral Nutrition-Associated Liver Disease
Intervention: Drug: Omegaven
39 Available cliniMACs HUD for T Cell Depletion
Condition: x Linked Combined Immunodeficiency
Intervention: Device: CliniMACs
40 Available Rivaroxaban or Apixaban in Mechanical Valves: RAMV
Condition: Thromboembolism
Interventions: Drug: Rivaroxaban;   Drug: Apixaban 5 MG [Eliquis]

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.